(icTV) HOT TOPICS RESULTS
The HIGH Randomised Clinical Trial
Elie Azoulay discusses results from his RCT on the effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with ARF. Full results from this trial were presented at the Hot Topics session at LIVES 2018 in Paris and published in JAMA.
Watch the full presentation here.
Read the article in JAMA here.